Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119,671 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tissue recommendations for precision cancer therapy using next generation sequencing: a comprehensive single cancer center's experiences.
Cho M, Ahn S, Hong M, Bang H, Van Vrancken M, Kim S, Lee J, Park SH, Park JO, Park YS, Lim HY, Kang WK, Sun JM, Lee SH, Ahn MJ, Park K, Kim DH, Lee S, Park W, Kim KM. Cho M, et al. Among authors: kim km, kim dh, kim s. Oncotarget. 2017 Jun 27;8(26):42478-42486. doi: 10.18632/oncotarget.17199. Oncotarget. 2017. PMID: 28477007 Free PMC article.
Bridging genomics and phenomics of gastric carcinoma.
Cho J, Ahn S, Son DS, Kim NK, Lee KW, Kim S, Lee J, Park SH, Park JO, Kang WK, An JY, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S, Kim KM. Cho J, et al. Among authors: kim km, kim s, kim nk. Int J Cancer. 2019 Nov 1;145(9):2407-2417. doi: 10.1002/ijc.32228. Epub 2019 Mar 18. Int J Cancer. 2019. PMID: 30801717 Free article.
The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors.
Kim H, Ahn S, Kim H, Hong JY, Lee J, Park SH, Park JO, Park YS, Lim HY, Kang WK, Kim KM, Kim ST. Kim H, et al. Among authors: kim st, kim km. J Cancer Res Clin Oncol. 2022 Sep;148(9):2427-2435. doi: 10.1007/s00432-021-03781-6. Epub 2021 Sep 12. J Cancer Res Clin Oncol. 2022. PMID: 34510272 Free PMC article.
Health-related quality-of-life analysis from KEYNOTE-590: pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer.
Mansoor W, Joo S, Norquist JM, Kato K, Sun JM, Shah MA, Enzinger P, Adenis A, Doi T, Kojima T, Metges JP, Li Z, Kim SB, Cho BC, Sunpaweravong P, Alsina Maqueda M, Goekkurt E, Suryawanshi S, Shah S, Shen L. Mansoor W, et al. Among authors: kim sb. Oncologist. 2024 May 30:oyae087. doi: 10.1093/oncolo/oyae087. Online ahead of print. Oncologist. 2024. PMID: 38815152
Active biointegrated living electronics for managing inflammation.
Shi J, Kim S, Li P, Dong F, Yang C, Nam B, Han C, Eig E, Shi LL, Niu S, Yue J, Tian B. Shi J, et al. Among authors: kim s. Science. 2024 May 31;384(6699):1023-1030. doi: 10.1126/science.adl1102. Epub 2024 May 30. Science. 2024. PMID: 38815037
119,671 results
You have reached the last available page of results. Please see the User Guide for more information.